BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World J Gastroenterol 2015; 21(10): 2988-2996 [PMID: 25780297 DOI: 10.3748/wjg.v21.i10.2988]
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2988.htm
Number Citing Articles
1
Lucy Oldfield, Rohith Rao, Lawrence N. Barrera, Eithne Costello. Pancreatic Cancer2018; : 1241 doi: 10.1007/978-1-4939-7193-0_86
2
Farshad Moradi, Andrei Iagaru. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder CancerSeminars in Nuclear Medicine 2020; 50(5): 434 doi: 10.1053/j.semnuclmed.2020.04.002
3
Shengyun Huang, Huanhuan Chong, Xun Sun, Zhijian Wu, Qing Jia, Yongxue Zhang, Xiaoli Lan. The Value of 18F-FDG PET/CT in Diagnosing Pancreatic Lesions: Comparison With CA19-9, Enhanced CT or Enhanced MRFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.668697
4
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utility of 18 Fludeoxyglucose in Preoperative Positon-Emission Tomography-Computed Tomography (PET-CT) in the Early Diagnosis of Exocrine Pancreatic Cancer: A Study of 139 Resected CasesCirugía Española (English Edition) 2016; 94(9): 511 doi: 10.1016/j.cireng.2016.11.006
5
Paula Ghaneh, Robert Hanson, Andrew Titman, Gill Lancaster, Catrin Plumpton, Huw Lloyd-Williams, Seow Tien Yeo, Rhiannon Tudor Edwards, Colin Johnson, Mohammed Abu Hilal, Antony P Higginson, Tom Armstrong, Andrew Smith, Andrew Scarsbrook, Colin McKay, Ross Carter, Robert P Sutcliffe, Simon Bramhall, Hemant M Kocher, David Cunningham, Stephen P Pereira, Brian Davidson, David Chang, Saboor Khan, Ian Zealley, Debashis Sarker, Bilal Al Sarireh, Richard Charnley, Dileep Lobo, Marianne Nicolson, Christopher Halloran, Michael Raraty, Robert Sutton, Sobhan Vinjamuri, Jonathan Evans, Fiona Campbell, Jon Deeks, Bal Sanghera, Wai-Lup Wong, John P Neoptolemos. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancerHealth Technology Assessment 2018; 22(7): 1 doi: 10.3310/hta22070
6
Zheng Yuan, Jian Zhang, Huan Yang, Xiao-Dan Ye, Li-Chao Xu, Wen-Tao Li. Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional TreatmentJournal of Vascular and Interventional Radiology 2016; 27(1): 20 doi: 10.1016/j.jvir.2015.10.003
7
Lucy Oldfield, Rohith Rao, Lawrence N Barrera, Eithne Costello. Pancreatic Cancer2017; : 1 doi: 10.1007/978-1-4939-6631-8_86-1
8
Siyang Wang, Hongcheng Shi, Feixing Yang, Xinyu Teng, Bo Jiang. The value of 18F-FDG PET/CT and carbohydrate antigen 19-9 in predicting lymph node micrometastases of pancreatic cancerAbdominal Radiology 2019; 44(12): 4057 doi: 10.1007/s00261-019-02248-0
9
Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy. Imaging modalities for characterising focal pancreatic lesionsCochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD010213.pub2
10
Heying Duan, Lucia Baratto, Andrei Iagaru. The Role of PET/CT in the Imaging of Pancreatic NeoplasmsSeminars in Ultrasound, CT and MRI 2019; 40(6): 500 doi: 10.1053/j.sult.2019.04.006
11
M Jones, S Higgs, S Dwerryhouse, V Markos, K Mason, C Green, A Nawwar, J Searle, I Lyburn. Combined positron emission tomography and contrast enhanced CT (PET/CeCT) is a feasible single investigation in the staging of oesophagogastric cancers: single-centre pilot study experience during the COVID-19 pandemicThe Annals of The Royal College of Surgeons of England 2023;  doi: 10.1308/rcsann.2023.0070
12
Michele Ghidini, Marta Vuozzo, Barbara Galassi, Paola Mapelli, Virginia Ceccarossi, Lucio Caccamo, Maria Picchio, Daniele Dondossola. The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic CancerCancers 2021; 13(16): 4155 doi: 10.3390/cancers13164155
13
Gilles Metrard, Clara Cohen, Matthieu Bailly. Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1373260
14
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysisInternational Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
15
G. E. Roitberg, O. Yu. Anikeeva. PET-CT monitoring in the treatment of pancreatic cancerSouth Russian Journal of Cancer 2020; 1(4): 54 doi: 10.37748/2687-0533-2020-1-4-7
16
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utilidad de la 18-fluorodeoxiglucosa en la tomografía por emisión de positrones-tomografía computarizada (PET-TC) preoperatoria en el diagnóstico precoz del cáncer de páncreas exocrino: estudio en 139 casos resecadosCirugía Española 2016; 94(9): 511 doi: 10.1016/j.ciresp.2016.07.007
17
Piotr Hogendorf, Aleksander Skulimowski, Adam Durczyński, Anna Kumor, Grażyna Poznańska, Aleksandra Oleśna, Joanna Rut, Janusz Strzelczyk. A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic LesionDisease Markers 2017; 2017: 1 doi: 10.1155/2017/8629712
18
Jeffrey H. Lee, Lisa S. Cassani, Priya Bhosale, William A. Ross. The endoscopist’s role in the diagnosis and management of pancreatic cancerExpert Review of Gastroenterology & Hepatology 2016; 10(9): 1027 doi: 10.1080/17474124.2016.1176910
19
Jing Yang, Sainan Li, Jingjing Li, Fan Wang, Kan Chen, Yuanyuan Zheng, Jianrong Wang, Wenxia Lu, Yuqing Zhou, Qin Yin, Huawei Zhang, Chuanyong Guo. A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancerPancreatology 2016; 16(4): 605 doi: 10.1016/j.pan.2016.04.033
20
Jing Zhang, Jiali Zhang, Jing Han. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinomaMedical Engineering & Physics 2022; 110: 103862 doi: 10.1016/j.medengphy.2022.103862
21
H. Duan, L. Baratto, R. Laudicella, F. Stracuzzi, S. Baldari, A. Iagaru. Molecular imaging of pancreatic neoplasmsClinical and Translational Imaging 2021; 9(2): 141 doi: 10.1007/s40336-020-00408-7
22
Domenico Tamburrino, Deniece Riviere, Mohammad Yaghoobi, Brian R Davidson, Kurinchi Selvan Gurusamy. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerCochrane Database of Systematic Reviews 2016; 2016(9) doi: 10.1002/14651858.CD011515.pub2
23
LIANG LIU, JINFENG XIANG, RUFU CHEN, DELIANG FU, DEFEI HONG, JIHUI HAO, YIXIONG LI, JIANGTAO LI, SHENGPING LI, YIPING MOU, GANG MAI, QUANXING NI, LI PENG, RENYI QIN, HONGGANG QIAN, CHENGHAO SHAO, BEI SUN, YONGWEI SUN, MIN TAO, BOLE TIAN, HONGXIA WANG, JIAN WANG, LIWEI WANG, WEI WANG, WEILIN WANG, JUN ZHANG, GANG ZHAO, JUN ZHOU, XIANJUN YU. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)International Journal of Oncology 2016; 48(3): 900 doi: 10.3892/ijo.2015.3316
24
O. P. Shesternikova, V. K. Finn, K. A. Lesko, L. V. Vinokurova. Intelligent System for Predicting the Feasibility of Using Computed TomographyScientific and Technical Information Processing 2023; 50(5): 464 doi: 10.3103/S0147688223050131